Literature DB >> 22009727

Role of substance P in the regulation of glucose metabolism via insulin signaling-associated pathways.

Iordanes Karagiannides1, Kyriaki Bakirtzi, Efi Kokkotou, Dimitris Stavrakis, Kara Gross Margolis, Thomas Thomou, Nino Giorgadze, James L Kirkland, Charalabos Pothoulakis.   

Abstract

Substance P (SP), encoded by the tachykinin 1 (Tac1) gene, is the most potent tachykinin ligand for the high-affinity neurokinin-1 receptor (NK-1R). We previously reported that NK-1R-deficient mice show less weight gain and reduced circulating levels of leptin and insulin in response to a high-fat diet (HFD) and demonstrated the presence of functional NK-1R in isolated human preadipocytes. Here we assessed the effects of SP on weight gain in response to HFD and determined glucose metabolism in Tac1-deficient (Tac1(-/-)) mice. The effect of SP on the expression of molecules that may predispose to reduced glucose uptake was also determined in isolated human mesenteric, omental, and sc preadipocytes. We show that although weight accumulation in response to HFD was similar between Tac1(-/-) mice and wild-type littermates, Tac1(-/-) mice demonstrated lower glucose and leptin and increased adiponectin blood levels and showed improved responses to insulin challenge after HFD. SP stimulated phosphorylation of c-Jun N-terminal kinase, protein kinase C, mammalian target of rapamycin, and inhibitory serine insulin receptor substrate-1 phosphorylation in human preadipocytes in vitro. Preincubation of human mesenteric preadipocytes with the protein kinase C pseudosubstrate inhibitor reduced insulin receptor substrate 1 phosphorylation in response to SP. Lastly, SP also induced insulin receptor substrate-1 phosphorylation in mature human sc adipocytes. Our results demonstrate an important role for SP in adipose tissue responses and obesity-associated pathologies. These novel SP effects on molecules that enhance insulin resistance at the adipocyte level may reflect an important role for this peptide in the pathophysiology of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009727      PMCID: PMC3230056          DOI: 10.1210/en.2011-1170

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  49 in total

1.  Hemokinin 1 is a full agonist at the substance P receptor.

Authors:  O Morteau; B Lu; C Gerard; N P Gerard
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

2.  Involvement of p38 and JNK MAPKs pathways in Substance P-induced production of TNF-alpha by peritoneal mast cells.

Authors:  Antonina Azzolina; Patrizia Guarneri; Nadia Lampiasi
Journal:  Cytokine       Date:  2002-04-21       Impact factor: 3.861

Review 3.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes.

Authors:  Tamara Tchkonia; Nino Giorgadze; Tamar Pirtskhalava; Yourka Tchoukalova; Iordanes Karagiannides; R Armour Forse; Matthew DePonte; Michael Stevenson; Wen Guo; Jianrong Han; Gerri Waloga; Timothy L Lash; Michael D Jensen; James L Kirkland
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-05       Impact factor: 3.619

5.  The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307).

Authors:  V Aguirre; T Uchida; L Yenush; R Davis; M F White
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

6.  Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.

Authors:  M Yuan; N Konstantopoulos; J Lee; L Hansen; Z W Li; M Karin; S E Shoelson
Journal:  Science       Date:  2001-08-31       Impact factor: 47.728

7.  Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.

Authors:  C Weyer; T Funahashi; S Tanaka; K Hotta; Y Matsuzawa; R E Pratley; P A Tataranni
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

8.  Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus.

Authors:  Toshimitsu Yatagai; Shoichiro Nagasaka; Ataru Taniguchi; Mitsuo Fukushima; Tomoatsu Nakamura; Akira Kuroe; Yoshikatsu Nakai; Shun Ishibashi
Journal:  Metabolism       Date:  2003-10       Impact factor: 8.694

9.  A central role for JNK in obesity and insulin resistance.

Authors:  Jiro Hirosumi; Gürol Tuncman; Lufen Chang; Cem Z Görgün; K Teoman Uysal; Kazuhisa Maeda; Michael Karin; Gökhan S Hotamisligil
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

10.  PKC-theta knockout mice are protected from fat-induced insulin resistance.

Authors:  Jason K Kim; Jonathan J Fillmore; Mary Jean Sunshine; Bjoern Albrecht; Takamasa Higashimori; Dong-Wook Kim; Zhen-Xiang Liu; Timothy J Soos; Gary W Cline; William R O'Brien; Dan R Littman; Gerald I Shulman
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

View more
  15 in total

1.  DOR activation inhibits anoxic/ischemic Na+ influx through Na+ channels via PKC mechanisms in the cortex.

Authors:  Dongman Chao; Xiaozhou He; Yilin Yang; Alia Bazzy-Asaad; Lawrence H Lazarus; Gianfranco Balboni; Dong H Kim; Ying Xia
Journal:  Exp Neurol       Date:  2012-05-15       Impact factor: 5.330

Review 2.  Origins and Functions of the Ventrolateral VMH: A Complex Neuronal Cluster Orchestrating Sex Differences in Metabolism and Behavior.

Authors:  William C Krause; Holly A Ingraham
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  An estrogen-responsive module in the ventromedial hypothalamus selectively drives sex-specific activity in females.

Authors:  Stephanie M Correa; David W Newstrom; James P Warne; Pierre Flandin; Clement C Cheung; Alexander T Lin-Moore; Andrew A Pierce; Allison W Xu; John L Rubenstein; Holly A Ingraham
Journal:  Cell Rep       Date:  2014-12-24       Impact factor: 9.423

Review 4.  Mechanisms and metabolic implications of regional differences among fat depots.

Authors:  Tamara Tchkonia; Thomas Thomou; Yi Zhu; Iordanes Karagiannides; Charalabos Pothoulakis; Michael D Jensen; James L Kirkland
Journal:  Cell Metab       Date:  2013-04-11       Impact factor: 27.287

Review 5.  Influence of Comorbidities: Neuropathy, Vasculopathy, and Diabetes on Healing Response Quality.

Authors:  Paul W Ackermann; David A Hart
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-10       Impact factor: 4.730

6.  Congenital ablation of Tacr2 reveals overlapping and redundant roles of NK2R signaling in the control of reproductive axis.

Authors:  Encarnacion Torres; Inmaculada Velasco; Delphine Franssen; Violeta Heras; Francisco Gaytan; Silvia Leon; Victor M Navarro; Rafael Pineda; M Luz Candenas; Antonio Romero-Ruiz; Manuel Tena-Sempere
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-01-11       Impact factor: 4.310

7.  Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor.

Authors:  D Hoang-Yen Tran; D Hoang-Ngoc Tran; S A Mattai; T Sallam; C Ortiz; E C Lee; L Robbins; S Ho; J E Lee; E Fisseha; C Shieh; A Sideri; D Q Shih; P Fleshner; D P B McGovern; M Vu; T C Hing; K Bakirtzi; M Cheng; B Su; I Law; I Karagiannides; S R Targan; R L Gallo; Z Li; H W Koon
Journal:  Int J Obes (Lond)       Date:  2016-05-10       Impact factor: 5.095

8.  Altered circadian feeding behavior and improvement of metabolic syndrome in obese Tac1-deficient mice.

Authors:  C A Maguire; S León; R S Carroll; U B Kaiser; V M Navarro
Journal:  Int J Obes (Lond)       Date:  2017-08-04       Impact factor: 5.095

Review 9.  DPP4 in Diabetes.

Authors:  Diana Röhrborn; Nina Wronkowitz; Juergen Eckel
Journal:  Front Immunol       Date:  2015-07-27       Impact factor: 7.561

10.  Substance P mediates pro-inflammatory cytokine release form mesenteric adipocytes in Inflammatory Bowel Disease patients.

Authors:  Aristea Sideri; Kyriaki Bakirtzi; David Q Shih; Hon Wai Koon; Phillip Fleshner; Razvan Arsenescu; Violeta Arsenescu; Jerrold R Turner; Iordanes Karagiannides; Charalabos Pothoulakis
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.